How do adenosine A2A receptors regulate motor function?

Parkinsonism Relat Disord. 2020 Nov:80 Suppl 1:S13-S20. doi: 10.1016/j.parkreldis.2020.09.025. Epub 2020 Dec 19.

Abstract

Adenosine A2A receptor antagonism is a new therapeutic strategy in the symptomatic treatment of Parkinson's disease (PD). This review addresses how adenosine A2A receptors are involved with the control of motor function via the basal ganglia-thalamocortical circuit, and considers the anatomical localization and physiological function of the receptor, along with its ultrastructural localization in critical areas/neurons of the circuit. Based on this understanding of the functional significance of the adenosine A2A receptor in the basal ganglia, the mode of action of A2A receptor antagonists is explored in terms of the dynamic functioning of the basal ganglia and the activity of the internal circuits of the striatum in PD. Finally, the pathophysiological differences between the normal and PD states are examined to emphasize the importance of the adenosine A2A receptor.

Keywords: A(2A) receptor antagonist; Adenosine; Adenosine A(2A) receptor; Basal ganglia; Cyclic AMP; Parkinson's disease; Striatopallidal pathway.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiparkinson Agents / therapeutic use*
  • Humans
  • Motor Activity / drug effects*
  • Neurons / drug effects
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Receptor, Adenosine A2A / drug effects*
  • Receptor, Adenosine A2A / metabolism
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Antiparkinson Agents
  • Receptor, Adenosine A2A
  • gamma-Aminobutyric Acid